Selective serotonin reuptake inhibitors yield additional antiplatelet protection in patients with congestive heart failure treated with antecedent aspirin-Reference-Cited by-同舟云学术

Selective serotonin reuptake inhibitors yield additional antiplatelet protection in patients with congestive heart failure treated with antecedent aspirin

Published:2003-08 Issue:4 Volume:5 Page:517-521
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European Journal of Heart Failure

Author:

Serebruany V.L.¹,Glassman A.H.²,Malinin A.I.¹,Atar D.³,Sane D.C.⁴,Oshrine B.R.¹,Ferguson J.J.⁵,O'Connor C.M.⁶

Affiliation:

1. Sinai Center for Thrombosis Research, Johns Hopkins University; 2401 West Belvedere Avenue, Schapiro Research Building-R 202 Baltimore; MD 21215 USA

2. Columbia University; New York NY USA

3. Frederiksberg Hospital; Copenhagen Denmark

4. Wake Forest University School of Medicine; Winston-Salem NC USA

5. Texas Heart Institute; Houston TX USA

6. Duke Clinical Research Institute; Durham NC USA

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Reference21 articles.

1. Relationship between hemostatic abnormalities and neuroendocrine activity in heart failure;Sbarouni;Am Heart J,1994

2. Abnormalities of hemorheological, endothelial, and platelet function in patients with chronic heart failure in sinus rhythm: effects of angiotensin-converting enzyme inhibitor and beta-blocker therapy;Gibbs;Circulation,2001